[ORIENT] YoY Cumulative Quarter Result on 31-Dec-2008 [#4]

Stock
[ORIENT] ORIENTAL HOLDINGS BHD
Announcement Date
24-Feb-2009
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2008
Quarter
31-Dec-2008 [#4]
Profit Trend
QoQ- -3.37%
YoY- -3.17%
Quarter Report
Latest QR
Upcoming QR
ORIENT's Result
ORIENT's Financial Summary
View:
Show?
Cumulative Result
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
Revenue 3,108,998 3,230,455 3,438,307 5,131,793 4,510,896 3,959,654 4,207,457 -4.91%
PBT 461,055 384,412 431,102 477,509 510,066 435,316 332,805 5.58%
Tax -91,808 -76,467 -93,904 -115,477 -120,430 -101,234 -62,217 6.69%
NP 369,247 307,945 337,198 362,032 389,636 334,082 270,588 5.31%
-
NP to SH 270,156 249,590 380,202 313,657 323,925 305,251 234,209 2.40%
-
Tax Rate 19.91% 19.89% 21.78% 24.18% 23.61% 23.26% 18.69% -
Total Cost 2,739,751 2,922,510 3,101,109 4,769,761 4,121,260 3,625,572 3,936,869 -5.86%
-
Net Worth 4,398,073 3,341,030 3,265,079 3,581,134 3,326,975 3,070,498 2,822,754 7.66%
Dividend
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
Div 18,609 45,218 51,692 82,720 118,898 118,901 104,680 -25.00%
Div Payout % 6.89% 18.12% 13.60% 26.37% 36.71% 38.95% 44.70% -
Equity
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
Net Worth 4,398,073 3,341,030 3,265,079 3,581,134 3,326,975 3,070,498 2,822,754 7.66%
NOSH 620,303 502,433 516,920 517,004 516,948 516,962 516,940 3.08%
Ratio Analysis
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
NP Margin 11.88% 9.53% 9.81% 7.05% 8.64% 8.44% 6.43% -
ROE 6.14% 7.47% 11.64% 8.76% 9.74% 9.94% 8.30% -
Per Share
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
RPS 501.21 642.96 665.15 992.60 872.60 765.95 813.92 -7.75%
EPS 43.55 40.23 43.63 60.67 62.65 59.05 45.30 -0.65%
DPS 3.00 9.00 10.00 16.00 23.00 23.00 20.25 -27.24%
NAPS 7.0902 6.6497 6.3164 6.9267 6.4358 5.9395 5.4605 4.44%
Adjusted Per Share Value based on latest NOSH - 528,181
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
RPS 501.13 520.71 554.21 827.18 727.10 638.25 678.19 -4.91%
EPS 43.55 40.23 61.28 50.56 52.21 49.20 37.75 2.40%
DPS 3.00 7.29 8.33 13.33 19.16 19.17 16.87 -25.00%
NAPS 7.0892 5.3853 5.2629 5.7724 5.3627 4.9493 4.5499 7.66%
Price Multiplier on Financial Quarter End Date
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
Date 30/12/11 30/12/10 31/12/09 31/12/08 31/12/07 29/12/06 30/12/05 -
Price 5.36 5.59 5.70 4.94 6.60 4.46 4.08 -
P/RPS 1.07 0.87 0.86 0.50 0.76 0.58 0.50 13.51%
P/EPS 12.31 11.25 7.75 8.14 10.53 7.55 9.01 5.33%
EY 8.13 8.89 12.90 12.28 9.49 13.24 11.10 -5.05%
DY 0.56 1.61 1.75 3.24 3.48 5.16 4.96 -30.46%
P/NAPS 0.76 0.84 0.90 0.71 1.03 0.75 0.75 0.22%
Price Multiplier on Announcement Date
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
Date 23/02/12 24/02/11 25/02/10 24/02/09 27/02/08 14/03/07 27/02/06 -
Price 6.34 5.14 5.60 4.78 6.00 4.66 4.14 -
P/RPS 1.26 0.80 0.84 0.48 0.69 0.61 0.51 16.26%
P/EPS 14.56 10.35 7.61 7.88 9.58 7.89 9.14 8.06%
EY 6.87 9.66 13.13 12.69 10.44 12.67 10.94 -7.45%
DY 0.47 1.75 1.79 3.35 3.83 4.94 4.89 -32.30%
P/NAPS 0.89 0.77 0.89 0.69 0.93 0.78 0.76 2.66%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment